Allergan sues rival over patents

Jan 28, 2019

Allergan sued rival Prollenium Medical Technologies in federal court for patent royalties on sales of its Revanesse Versa+ wrinkle-filler, claiming Versa+ infringes two of Allergan's patents for Juvedérm.

The patents cover formulations for and methods of manufacturing the filler compositions that include lidocaine, an anesthetic, added by Allergan as a way to take some of the sting out of the injection process. Juvedérm products had U.S. sales of $389.8 million during the first nine months of 2018.

Allergan is demanding cash compensation from Canada-based Prollenium and an order blocking sales of Versa+.

Read the Bloomberg coverage

Don't miss your Daily Dose.  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments